Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil

  The companies are understandably reluctant to create competitors with knowledge and capabilities in the most up-to-date production methods and most advanced vaccines. [...]the developing country partner may obtain out-of-date technology for older vaccines. Besides this, a federal regulatory agency...

Full description

Saved in:
Bibliographic Details
Published inPLoS neglected tropical diseases Vol. 5; no. 11; p. e1300
Main Authors Ho, Paulo Lee, Miyaji, Eliane Namie, Oliveira, Maria Leonor Sarno, Dias, Waldely de Oliveira, Kubrusly, Flavia Saldanha, Tanizaki, Martha Massako, Martins, Elizabeth Angélica Leme, Raw, Isaias
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.11.2011
Public Library of Science (PLoS)
Subjects
Agreements
Brazil - epidemiology
Care and treatment
Communicable Diseases - epidemiology
Developing Countries
Hepatitis B
Humans
Immunization
LDCs
Medicine
Policy Platform
Science Policy
Technology transfer
Vaccination
Vaccination - economics
Vaccination - methods
Vaccines
Vaccines - economics
Vaccines - supply & distribution
Brazil
Brazil
Developing Countries
Vaccines
Communicable Diseases
Humans
Vaccination
Online AccessGet full text

Cover

Abstract   The companies are understandably reluctant to create competitors with knowledge and capabilities in the most up-to-date production methods and most advanced vaccines. [...]the developing country partner may obtain out-of-date technology for older vaccines. Besides this, a federal regulatory agency (ANVISA) was created that certifies the production laboratories and promotes a move to full compliance with WHO GMP guidance, a process that is not instantaneous but depends on investments that the MH began to make available starting in 1985. [...]the country should ensure the capability to undertake rigorous epidemiological studies to guide and evaluate the delivery of vaccination services.
AbstractList   The companies are understandably reluctant to create competitors with knowledge and capabilities in the most up-to-date production methods and most advanced vaccines. [...]the developing country partner may obtain out-of-date technology for older vaccines. Besides this, a federal regulatory agency (ANVISA) was created that certifies the production laboratories and promotes a move to full compliance with WHO GMP guidance, a process that is not instantaneous but depends on investments that the MH began to make available starting in 1985. [...]the country should ensure the capability to undertake rigorous epidemiological studies to guide and evaluate the delivery of vaccination services.
Audience Academic
Author Raw, Isaias
Kubrusly, Flavia Saldanha
Tanizaki, Martha Massako
Martins, Elizabeth Angélica Leme
Dias, Waldely de Oliveira
Ho, Paulo Lee
Miyaji, Eliane Namie
Oliveira, Maria Leonor Sarno
AuthorAffiliation Yale School of Public Health, United States of America
1 Instituto Butantan, São Paulo, SP, Brazil
2 Fundação Butantan, São Paulo, SP, Brazil
AuthorAffiliation_xml – name: 2 Fundação Butantan, São Paulo, SP, Brazil
– name: 1 Instituto Butantan, São Paulo, SP, Brazil
– name: Yale School of Public Health, United States of America
Author_xml – sequence: 1
  givenname: Paulo Lee
  surname: Ho
  fullname: Ho, Paulo Lee
  organization: Instituto Butantan, São Paulo, SP, Brazil
– sequence: 2
  givenname: Eliane Namie
  surname: Miyaji
  fullname: Miyaji, Eliane Namie
– sequence: 3
  givenname: Maria Leonor Sarno
  surname: Oliveira
  fullname: Oliveira, Maria Leonor Sarno
– sequence: 4
  givenname: Waldely de Oliveira
  surname: Dias
  fullname: Dias, Waldely de Oliveira
– sequence: 5
  givenname: Flavia Saldanha
  surname: Kubrusly
  fullname: Kubrusly, Flavia Saldanha
– sequence: 6
  givenname: Martha Massako
  surname: Tanizaki
  fullname: Tanizaki, Martha Massako
– sequence: 7
  givenname: Elizabeth Angélica Leme
  surname: Martins
  fullname: Martins, Elizabeth Angélica Leme
– sequence: 8
  givenname: Isaias
  surname: Raw
  fullname: Raw, Isaias
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22140586$$D View this record in MEDLINE/PubMed
BookMark eNptUl2LGyEUHcqW7kf7D0o7UGhfOqkf46gvhd1l2wYW-tI-y43jJC5GU3UC219fk8wuCRQVL95zjtfruazOfPCmqt5iNMOU4y8PYYwe3Gzjcz9DCGGK0IvqAkvKGsIpOzuKz6vLlB4QYpIJ_Ko6JwS3iInuonq808GHtdXg6i240dRhKIHW1ptUDyHWeWXq3myNCxvrl7UOo8_RmtQ0u4yGtKfMfco2jznUN2MGX-bnGurNuHBW13ZK2uBLXN9E-Gvd6-rlAC6ZN9N-Vf3-dvfr9kdz__P7_Pb6vtGl2tyU6ntKNaOd6LFedJpwGDAHwD0szCAlFlyU50hNaFkSaWYADwyIoXLBgF5V7w-6GxeSmrqWFCZCYEQJwwUxPyD6AA9qE-0a4qMKYNX-IMSlgpitdkZRg9pyJyLciFaKXlDQsuWctoBR13dF6-t027hYm16b0ixwJ6KnGW9Xahm2ihLSMSqKwKdJIIY_o0lZrW3SxjnwJoxJSSR4SxknBfnhgFxCqcz6IRRBvUOra1IwiDO505v9B1VGb8qvF0sNtpyfED4eEVYGXF6l4Pa_l06B7QGoY0gpmuH5lRipnUWfmq12FlWTRQvt3XGHnklPnqT_ANae5eg
CitedBy_id crossref_primary_10_1016_j_vaccine_2014_07_069
crossref_primary_10_1038_s41598_022_11851_z
crossref_primary_10_4161_hv_23163
crossref_primary_10_1371_journal_pone_0286224
crossref_primary_10_1016_j_provac_2015_05_001
crossref_primary_10_1016_j_tmaid_2022_102441
crossref_primary_10_1016_j_toxicon_2012_02_008
crossref_primary_10_1128_CVI_00134_14
crossref_primary_10_1016_j_vaccine_2017_04_087
crossref_primary_10_1371_journal_pntd_0002862
Cites_doi 10.1016/j.vaccine.2009.04.047
10.1371/journal.pone.0010863
10.1016/j.vaccine.2010.01.044
10.1016/j.vaccine.2009.06.004
10.1016/j.vaccine.2011.04.127
10.1136/jech.2008.085712
10.1586/14760584.4.2.173
10.1128/CVI.00339-08
10.1097/INF.0b013e3181c15471
10.1016/j.vaccine.2009.12.026
10.1016/j.vaccine.2007.11.048
ContentType Journal Article
Copyright COPYRIGHT 2011 Public Library of Science
Ho et al. 2011
2011 Ho et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Ho PL, Miyaji EN, Oliveira MLS, Dias WdO, Kubrusly FS, et al. (2011) Economical Value of Vaccines for the Developing Countries--The Case of Instituto Butantan, a Public Institution in Brazil. PLoS Negl Trop Dis 5(11): e1300. doi:10.1371/journal.pntd.0001300
Copyright_xml – notice: COPYRIGHT 2011 Public Library of Science
– notice: Ho et al. 2011
– notice: 2011 Ho et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Ho PL, Miyaji EN, Oliveira MLS, Dias WdO, Kubrusly FS, et al. (2011) Economical Value of Vaccines for the Developing Countries--The Case of Instituto Butantan, a Public Institution in Brazil. PLoS Negl Trop Dis 5(11): e1300. doi:10.1371/journal.pntd.0001300
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1371/journal.pntd.0001300
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-2735
Editor Aksoy, Serap
Editor_xml – sequence: 1
  givenname: Serap
  surname: Aksoy
  fullname: Aksoy, Serap
EndPage e1300
ExternalDocumentID 1288103251
oai_doaj_org_article_3e04f99027e8498d83ac947734a106d6
A274307598
10_1371_journal_pntd_0001300
22140586
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GeographicLocations Brazil
GeographicLocations_xml – name: Brazil
GroupedDBID ---
123
29O
2WC
3V.
53G
5VS
7X7
88E
8C1
8FI
8FJ
AAFWJ
ABDBF
ABUWG
ACGFO
ACIHN
ACPRK
ADBBV
ADRAZ
AEAQA
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
BWKFM
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAP
EAS
EBD
ECGQY
ECM
EIF
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PV9
RIG
RNS
RPM
RZL
SV3
TR2
TUS
UKHRP
WOQ
AAYXX
AFPKN
CITATION
7X8
5PM
AAPBV
ABPTK
ID FETCH-LOGICAL-c595t-735d33c5368d1cb6c27af17aa1dabef9918782149c239c290c5ea1f5a2e39b5a3
IEDL.DBID RPM
ISSN 1935-2735
1935-2727
IngestDate Sun Oct 01 00:20:27 EDT 2023
Tue Oct 22 15:13:52 EDT 2024
Tue Sep 17 21:19:20 EDT 2024
Fri Oct 25 09:26:23 EDT 2024
Thu Feb 22 23:24:32 EST 2024
Fri Feb 02 04:26:09 EST 2024
Tue Aug 20 22:01:21 EDT 2024
Thu Sep 12 17:56:01 EDT 2024
Tue Oct 15 23:47:46 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Brazil
Developing Countries
Vaccines
Communicable Diseases
Humans
Vaccination
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c595t-735d33c5368d1cb6c27af17aa1dabef9918782149c239c290c5ea1f5a2e39b5a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226538/
PMID 22140586
PQID 908743572
PQPubID 23479
ParticipantIDs plos_journals_1288103251
doaj_primary_oai_doaj_org_article_3e04f99027e8498d83ac947734a106d6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3226538
proquest_miscellaneous_908743572
gale_infotracmisc_A274307598
gale_infotracacademiconefile_A274307598
gale_healthsolutions_A274307598
crossref_primary_10_1371_journal_pntd_0001300
pubmed_primary_22140586
PublicationCentury 2000
PublicationDate 2011-11-01
PublicationDateYYYYMMDD 2011-11-01
PublicationDate_xml – month: 11
  year: 2011
  text: 2011-11-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco, USA
PublicationTitle PLoS neglected tropical diseases
PublicationTitleAlternate PLoS Negl Trop Dis
PublicationYear 2011
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References 21684420 - Vaccine. 2011 Jul 1;29 Suppl 1:A12-5
15889991 - Expert Rev Vaccines. 2005 Apr;4(2):173-84
20466706 - J Epidemiol Community Health. 2010 Jul;64(7):563-4
18155811 - Vaccine. 2008 Jan 30;26(5):647-52
19393709 - Vaccine. 2009 Jun 24;27(31):4219-24
19545935 - Vaccine. 2009 Aug 21;27 Suppl 3:C22-4
19935447 - Pediatr Infect Dis J. 2010 Apr;29(4):289-93
20523738 - PLoS One. 2010;5(5):e10863
20123051 - Vaccine. 2010 Mar 16;28(13):2505-9
19261771 - Clin Vaccine Immunol. 2009 Apr;16(4):544-50
20044050 - Vaccine. 2010 Feb 25;28(9):2130-6
JA Bettinger (ref6) 2010; 28
K Mulholland (ref11) 2010; 64
MS Brasil (ref12) 2009
W Quintilio (ref5) 2009; 27
C Miyaki (ref1) 2011; 29
EF Carniel (ref10) 2008; 26
C Miyaki (ref4) 2010; 28
M Watanabe (ref2) 2005; 4
TQ Zorzeto (ref3) 2009; 16
R Dagan (ref7) 2009; 27
KK Hsu (ref8) 2010; 29
ML Oliveira (ref9) 2010; 5
References_xml – volume: 27
  start-page: 4219
  year: 2009
  ident: ref5
  article-title: Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.04.047
  contributor:
    fullname: W Quintilio
– year: 2009
  ident: ref12
  article-title: Guia de Vigilância Epidemiológica. Brasília: Ministério da Saúde.
  contributor:
    fullname: MS Brasil
– volume: 5
  start-page: e10863
  year: 2010
  ident: ref9
  article-title: Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0010863
  contributor:
    fullname: ML Oliveira
– volume: 28
  start-page: 2505
  year: 2010
  ident: ref4
  article-title: Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations.
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2010.01.044
  contributor:
    fullname: C Miyaki
– volume: 27
  start-page: C22
  year: 2009
  ident: ref7
  article-title: Serotype replacement in perspective.
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.06.004
  contributor:
    fullname: R Dagan
– volume: 29
  start-page: A12
  year: 2011
  ident: ref1
  article-title: Influenza vaccine production for Brazil: A classic example of successful Noth-South bilateral technology transfer.
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2011.04.127
  contributor:
    fullname: C Miyaki
– volume: 64
  start-page: 563
  year: 2010
  ident: ref11
  article-title: Confidence in vaccines in developing countries: social, cultural, economic and political influences.
  publication-title: J Epidemiol Community Health
  doi: 10.1136/jech.2008.085712
  contributor:
    fullname: K Mulholland
– volume: 4
  start-page: 173
  year: 2005
  ident: ref2
  article-title: Acellular pertussis vaccines in Japan: past, present and future.
  publication-title: Expert Rev Vaccines
  doi: 10.1586/14760584.4.2.173
  contributor:
    fullname: M Watanabe
– volume: 16
  start-page: 544
  year: 2009
  ident: ref3
  article-title: Immunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in infants.
  publication-title: Clin Vaccine Immunol
  doi: 10.1128/CVI.00339-08
  contributor:
    fullname: TQ Zorzeto
– volume: 29
  start-page: 289
  year: 2010
  ident: ref8
  article-title: Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001–2007.
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0b013e3181c15471
  contributor:
    fullname: KK Hsu
– volume: 28
  start-page: 2130
  year: 2010
  ident: ref6
  article-title: The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007.
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.12.026
  contributor:
    fullname: JA Bettinger
– volume: 26
  start-page: 647
  year: 2008
  ident: ref10
  article-title: Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.11.048
  contributor:
    fullname: EF Carniel
SSID ssj0059581
Score 2.0881171
SecondaryResourceType review_article
Snippet   The companies are understandably reluctant to create competitors with knowledge and capabilities in the most up-to-date production methods and most advanced...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e1300
SubjectTerms Agreements
Brazil - epidemiology
Care and treatment
Communicable Diseases - epidemiology
Developing Countries
Hepatitis B
Humans
Immunization
LDCs
Medicine
Policy Platform
Science Policy
Technology transfer
Vaccination
Vaccination - economics
Vaccination - methods
Vaccines
Vaccines - economics
Vaccines - supply & distribution
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1BaxUxEA7yDuJF1KrdWmsOghfTJptkkxz7iqUU6slCbyGbZPFB2X30vXfQX-8k2X12RfDi4cHyZgKbmclkZpP5BqGP3FNtIPEhwXWKCMYMcaIVRGjailY3VOT-KTdfm6tbcX0n7x61-kp3wgo8cBHcGY9UdOAyaxW1MDpo7rwRSnHhIJsJBWybmimZKj5YGqnZWCjHFTsb9XK67rfhtJzW0dlGlPH69155sb4fNn8LOf-8OfloK7p8gZ6PMSQ-L-_-Ej2J_Sv09GY8JT9AP6ZqY2BKYN4RDx08-ETdYIhSMUR9-He5FM4NI1LOTEiieNjZ0pDpIsGAl7vUbNj1n7HDBRgbr0Yi6BWe8fLB_Vzdv0a3l1--XVyRscUC8SCjLVFcBs695I0OzLeNr5XrmHKOBddGkDvTEEJAFuVrDj9DvYyOddLVkZtWOv4GLfqhj4cIN077hrpWdRp048ECvOzqwIRUdSN9qBCZ5G3XBUnD5uM0BRlIEZxN-rGjfiq0TErZ8yYc7PwHWIcdrcP-yzoq9CGp1Jai0v1qtueQjIN3k0ZX6FPmSOsZVOrdWJYAk0rIWDPO4xknrEM_Ix8ms5nmsrGw8-sEVyhZhfBkSjaNSvfa-jjsNtZQDeNBQhV6WyxrP98axE6lhimomc3NBDKn9KvvGSAcnHQDG9nR_5DgO_Qsf0bP5ZfHaLF92MX3EIdt25O85H4B13gwLA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3LatwwUIQNlF5K33GTtDoUeqkW25Is-VBCtjSEQnrqQm5CluV2YbE3611o-vWZkR-pS0oPBuMZGc9LmrE0M4S85y7WOQQ-rLSVYiJJcmZFIZjQcSEKncUi9E-5-pZdLsXXa3l9QIaerT0D2wdDO-wntdyu579ubs_A4D-Frg0qGQbNN_WunHd7cRDEH6aYDISH-cS4ryBzGdqWgteCmVip6pPp_vWWyWIVavqPM_dss27ah9zSv09X_rFcXTwlT3o_k553ivGMHPj6OXl01e-kvyC3Q0YyIGHBb0-bCm4cQlsKniwFz5Dep1TR0FQC42rGEOJg9cMhw2GDhi722JDY1h-ppV3xbLrqgSB7uKeLrf29Wr8ky4sv3z9fsr4NA3PArx1TXJacO8kzXSauyFyqbJUoa5PSFr4CB1ODmwGRlks5XHnspLdJJW3qeV5Iy1-RWd3U_ojQzGqXxbZQlebCOtASJ6u0TIRUaSZdGRE28NtsumobJmy5KYhSOsYZlI_p5RORBQplxMVa2eFBs_1hetMz3McCvhLib69FrkvNrcuFUvAFEA-XWUTeoUhNl3g6Wrw5h4AdZkCZ64h8CBiohSBSZ_vUBSAKq2dNME8mmGCrbgI-QrUZaGkNeAcaSxrKJCJ0UCWDo_DsW-2bfWvyWMN44FBEXneaNdKbAttjqYEENdG5CUOmkHr1MxQRh4k8g8XuzX-JPyaPw3_0kH95Qma77d6fgiO2K94G27oDUlgxsQ
  priority: 102
  providerName: Scholars Portal
Title Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil
URI https://www.ncbi.nlm.nih.gov/pubmed/22140586
https://search.proquest.com/docview/908743572
https://pubmed.ncbi.nlm.nih.gov/PMC3226538
https://doaj.org/article/3e04f99027e8498d83ac947734a106d6
http://dx.doi.org/10.1371/journal.pntd.0001300
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtQwcNQuEuKCeDdQFh-QuJDdJLZj59hdWlVIW1WIor1ZjuPASttktY9LT3wEX8iXMHYeahAnDomieCzZ87Bn7HkAvKcmkhkaPmGhSxGyOM5CzXIWMhnlLJdpxHz9lMVVennDPi_58gh4FwvjnfZNvppU69tJtfrhfSs3t2ba-YlNrxdzZMIUBXV6DMfIoJ2J3iy_POO-MikqJi7YKhFtvBwV8bQlz2RT7YtJc2nnKsElCVoZ3EVT39uafAb_fp0ebdb17l9K6N--lPc2p4sn8LjVKslZM_qncGSrZ_Bw0d6bP4e7Lv4Ygb7p9cGSusQP41p3BPVWgnog-dQHUBEXqu5Kbe1-__yFnETmuNm5Pp1vQU1mB1d_WFcfiSbN2V_fiKQmq4rMtvputX4BNxfnX-eXYVt1ITSIu30oKC8oNZymsohNnppE6DIWWseFzm2J-qRErQINK5NQfLLIcKvjkuvE0iznmr6EUVVX9gRIqqVJI52LUlKmDTKF4WVSxIwLJKApAgg7hKtNk1xD-Rs2gUZJgznlaKVaWgUwc1TpYV1qbP-j3n5XLYMoaiOGo0Rz20qWyUJSbTImBI4Azd8iDeCdo6lq4kx7AVdnaJ_jgsczGcAHD-FEHGlqdBupgJNyybIGkKcDSBRNM2g-cXzTzWWnUBmQLoMhjwMgHS8p18u5ulW2PuxUFknsjxgK4FXDWv18O0YNQAyYboCQYQuKkM8Z3orM6__u-QYe-eN0H4Z5CqP99mDfoj62z8cohUuBbzmPx_Bgdn51_WXszzbwvWBy7OXzDwHrOW0
link.rule.ids 230,315,730,783,787,867,888,2109,2228,24331,27937,27938,31733,33280,33758,53805,53807
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4tRQIuvJcNLKwPSFxIm8R27By3hVWB7YrD7mpvluMkUNFNqj4uPfEj-IX8EsbOQ5sVFzhUrTpjKeP5bM_E8wB4S00gE3R8_EwXwmdhmPiapcxnMkhZKuOAuf4ps7N4esE-X_GrPeBtLowL2jfpfFgurofl_LuLrVxem1EbJzb6OpsgCGNcqKM7cBe_At466fUGzBPuepOiaWLTrSLRZMxREY4aBQ2X5SYb1td2thdcFKGfwW0-9Y3DydXw73bqwXJRrf9mht6OprxxPJ08gstWsDoq5cdwu0mHZner5uM_S_4YHjYGKzmuyU9gLy-fwr1ZcyX_DHZtajMyXerFNidVgT-Mpa4JmsQETUzyocvNIjYL3nbxWv_--QtBSiZ4jtoxbdhCRcZb29pYl--JJvVrxY6IKCLzkoxXejdfPIeLk4_nk6nfNHTwDSpl4wvKM0oNp7HMQpPGJhK6CIXWYabTvEBTVaLBgj6biSh-ksDwXIcF11FOk5Rrug-DsirzAyCxliYOdCoKSZk2iDfDiygLGRc4QybzwG81qZZ13Q7lLu8E-jv1zCkLAtWAwIOxVXfHa6tuuz-q1TfVaEDRPGD4lOjJ55IlMpNUm4QJgU-AnnUWe3BkwaLqFNZu71DH6PrjXsoT6cE7x2F3DwSL0U0SBApl63D1OA97nLjqTY98YAHZyrJWaGdIWxyRhx6QFqTKjrJRdGVebdcqCSSOxxny4EWN2U7edgV4IHpo7k1In4IYdeXIG0y-_O-RR3B_ej47Vaefzr68ggfurb3L9jyEwWa1zV-j2bdJ37hF_gd9RlZE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLWgSCM2vGECA-MFEhuSJrEdO8tph2p4dDQLBo3YWI6TQEUnqZpk0xUfwRfyJVw7DzUjVrOoFNXXUq59bJ8b3wdCb4n2RQyGj5uqnLs0CGJX0YS6VPgJTUTkU1s_ZXkenV3ST1fsaq_Ul3Xa18nKK9bXXrH6aX0rN9d62vuJTS-WcwBhBAt1uknz6V10j5mk6b2h3m7CLGa2PinQExNyFfIuao7wYNpNkrcp6tRrr-5MPbgwBFuDmZjqvQPK5vEfduvJZl1W_6OiNz0q946oxUP0vVeu9Uz55TV14undjbyPt9L-EXrQEVd80oo8Rney4gk6WHZX80_Rrg9xBqFvat1kuMzhQZvWCgM1xkA18ekQo4VNNLyp5lX9_f0HwIrncJ6aPr37QolnjSlxrIr3WOH28-LQCGjCqwLPtmq3Wj9Dl4sPX-dnblfYwdUwMbXLCUsJ0YxEIg10EumQqzzgSgWpSrIcKKsA4gK2mw4J_GJfs0wFOVNhRuKEKfIcTYqyyA4RjpTQka8SngtClQbcaZaHaUAZh1HSqYPcfjblps3fIe0lHge7px05aYAgOyA4aGamfJA12bftH-X2h-xmQZLMp_CWYNFngsYiFUTpmHIObwAWdho56NgARrahrMMeIk9C4GvA0WLhoHdWwuwiABitumAIUMrk4xpJHo0kYfXrUfOhAWWvSyWBbwiTJJEFDsI9UKXpZbzpiqxsKhn7AvrDCDnoRYvbQd9-FTiIjxA9GpBxC-DUpiXvcPny1j2P0cHF6UJ--Xj--RW6bz_e26DPIzSpt032Gthfnbyx6_wfFT9YxA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Economical+value+of+vaccines+for+the+developing+countries--the+case+of+Instituto+Butantan%2C+a+public+institution+in+Brazil&rft.jtitle=PLoS+neglected+tropical+diseases&rft.au=Oliveira%2C+Maria+Leonor+Sarno&rft.au=Ho%2C+Paulo+Lee&rft.au=Miyaji%2C+Eliane+Namie&rft.au=de+Oliveira+Dias%2C+Waldely&rft.date=2011-11-01&rft.pub=Public+Library+of+Science&rft.issn=1935-2727&rft.volume=5&rft.issue=11&rft_id=info:doi/10.1371%2Fjournal.pntd.0001300&rft.externalDBID=n%2Fa&rft.externalDocID=A274307598
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1935-2735&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1935-2735&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1935-2735&client=summon